- Home
- CHEK vs SXTP Comparison
CHEK vs SXTP Comparison
Compare CHEK & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- SXTP
- Stock Information
- Founded
- CHEK 2004
- SXTP 2010
- Country
- CHEK Israel
- SXTP United States
- Employees
- CHEK 85
- SXTP N/A
- Industry
- CHEK Medical Electronics
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- CHEK Health Care
- SXTP Health Care
- Exchange
- CHEK Nasdaq
- SXTP Nasdaq
- Market Cap
- CHEK 3.9M
- SXTP 3.4M
- IPO Year
- CHEK 2015
- SXTP 2023
- Fundamental
- Price
- CHEK $0.67
- SXTP $1.38
- Analyst Decision
- CHEK
- SXTP Buy
- Analyst Count
- CHEK 0
- SXTP 2
- Target Price
- CHEK N/A
- SXTP $3.00
- AVG Volume (30 Days)
- CHEK 483.5K
- SXTP 88.9K
- Earning Date
- CHEK 11-28-2025
- SXTP 08-13-2025
- Dividend Yield
- CHEK N/A
- SXTP N/A
- EPS Growth
- CHEK N/A
- SXTP N/A
- EPS
- CHEK N/A
- SXTP N/A
- Revenue
- CHEK N/A
- SXTP $984,494.00
- Revenue This Year
- CHEK N/A
- SXTP $81.41
- Revenue Next Year
- CHEK N/A
- SXTP $95.63
- P/E Ratio
- CHEK N/A
- SXTP N/A
- Revenue Growth
- CHEK N/A
- SXTP 128.70
- 52 Week Low
- CHEK $0.56
- SXTP $1.22
- 52 Week High
- CHEK $3.04
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- CHEK 48.44
- SXTP 46.88
- Support Level
- CHEK $0.63
- SXTP $1.22
- Resistance Level
- CHEK $1.06
- SXTP $1.52
- Average True Range (ATR)
- CHEK 0.08
- SXTP 0.08
- MACD
- CHEK 0.01
- SXTP 0.04
- Stochastic Oscillator
- CHEK 15.22
- SXTP 54.10
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.